300298.SHE · Sinocare Inc

-

Please sign in to comment on 300298.SHE

1 Comment

Admin

4 years ago

Sinocare Inc is currently in a long term downtrend where the price is trading 11.1% below its 200 day moving average.

From a valuation standpoint, the stock is 12.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.

Sinocare Inc's total revenue rose by 25.5% to $557M since the same quarter in the previous year.

Its net income has increased by 8.8% to $91M since the same quarter in the previous year.

Finally, its free cash flow grew by 1240.3% to $73M since the same quarter in the previous year.

Based on the above factors, Sinocare Inc gets an overall score of 4/5.

Exchange	SHE
CurrencyCode	CNY
ISIN	CNE100001CJ0
Sector	Healthcare
Industry	Medical Devices

Market Cap	12B
PE Ratio	37.17
Target Price	30.5467
Beta	0.27
Dividend Yield	0.8%

ABOUT

Sinocare Inc

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to approximately 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.

300298.SHE · Sinocare Inc

-

Sinocare Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Sinocare Inc using a moving average strategy